Elizabeth Garrett-Mayer to Cancer Vaccines
This is a "connection" page, showing publications Elizabeth Garrett-Mayer has written about Cancer Vaccines.
Connection Strength
0.246
-
A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer. Cancer Immunol Res. 2014 Oct; 2(10):949-61.
Score: 0.112
-
K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate. Clin Cancer Res. 2010 Jan 01; 16(1):338-47.
Score: 0.081
-
HER-2/neu-specific monoclonal antibodies collaborate with HER-2/neu-targeted granulocyte macrophage colony-stimulating factor secreting whole cell vaccination to augment CD8+ T cell effector function and tumor-free survival in Her-2/neu-transgenic mice. J Immunol. 2003 Aug 15; 171(4):2161-9.
Score: 0.052